These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 25087504)

  • 21. Sentinel lymph node biopsy in early breast cancer: the first 100 cases performed in a teaching institute.
    Mahajna A; Hershko DD; Israelit S; Abu-Salih A; Keidar Z; Krausz MM
    Isr Med Assoc J; 2003 Aug; 5(8):556-9. PubMed ID: 12929292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sentinel lymph node biopsy indications and controversies in breast cancer.
    Wiatrek R; Kruper L
    Maturitas; 2011 May; 69(1):7-10. PubMed ID: 21411254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Controversial indications for sentinel lymph node biopsy in breast cancer patients.
    Assi H; Sbaity E; Abdelsalam M; Shamseddine A
    Biomed Res Int; 2015; 2015():405949. PubMed ID: 25821800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can we define a role for perisentinel lymph-nodes on breast cancer disease?
    Sianesi M; Del Rio P; Martella E; De Notarpietro F; De Simone B; Ghirarduzzi A; Sianesi N; Arcuri MF
    Ann Ital Chir; 2011; 82(3):173-7. PubMed ID: 21780557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is there a requirement for axillary lymph node dissection following identification of micro-metastasis or isolated tumour cells at sentinel node biopsy for breast cancer?
    Joyce DP; Solon JG; Prichard RS; Power C; Hill AD
    Surgeon; 2012 Dec; 10(6):326-9. PubMed ID: 22386798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concordance between peri-areolar blue dye and peri-incisional radiotracer injections for sentinel node mapping in patients with a history of primary breast cancer excisonal biopsy.
    Mehrabibahar M; Azizi S; Jangjoo A; Saremi E; Kakhki VR; Sadeghi R; Chicken DW; Keshtgar M
    Acta Chir Belg; 2014; 114(1):31-3. PubMed ID: 24720135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinically node-negative breast cancer, internal mammary lymph nodes, and sentinel lymph node biopsy.
    Ramsay SC; Cassidy N; Meade S
    Clin Nucl Med; 2008 Jun; 33(6):391-3. PubMed ID: 18496443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sentinel lymph node biopsy in breast cancer: a history and current clinical recommendations.
    D'Angelo-Donovan DD; Dickson-Witmer D; Petrelli NJ
    Surg Oncol; 2012 Sep; 21(3):196-200. PubMed ID: 22237143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Sentinel-node biopsy--update and current controversies].
    Sato K
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():207-10. PubMed ID: 17679199
    [No Abstract]   [Full Text] [Related]  

  • 30. Superparamagnetic iron oxide as a tracer for sentinel node biopsy in breast cancer: A comparative non-inferiority study.
    Piñero-Madrona A; Torró-Richart JA; de León-Carrillo JM; de Castro-Parga G; Navarro-Cecilia J; Domínguez-Cunchillos F; Román-Santamaría JM; Fuster-Diana C; Pardo-García R;
    Eur J Surg Oncol; 2015 Aug; 41(8):991-7. PubMed ID: 25997792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinicopathologic issues related to sentinel lymph node biopsy in breast cancer patients].
    Li DL; Yang WT
    Zhonghua Bing Li Xue Za Zhi; 2010 Nov; 39(11):725-8. PubMed ID: 21215160
    [No Abstract]   [Full Text] [Related]  

  • 32. Sentinel node biopsy in ectopic breast cancer.
    Gentilini O; Paganelli G; Trifiro G; Veronesi P
    Nucl Med Commun; 2003 Nov; 24(11):1127-8. PubMed ID: 14569165
    [No Abstract]   [Full Text] [Related]  

  • 33. A systematic review and meta-analyses of sentinel lymph node identification in breast cancer and melanoma, a plea for tracer mapping.
    Niebling MG; Pleijhuis RG; Bastiaannet E; Brouwers AH; van Dam GM; Hoekstra HJ
    Eur J Surg Oncol; 2016 Apr; 42(4):466-73. PubMed ID: 26853759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sentinel lymph node mapping in breast cancer: a critical reappraisal of the internal mammary chain issue.
    Manca G; Volterrani D; Mazzarri S; Duce V; Svirydenka A; Giuliano A; Mariani G
    Q J Nucl Med Mol Imaging; 2014 Jun; 58(2):114-26. PubMed ID: 24835288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sentinel lymph node biopsy in breast cancer--is lymphoscintigraphy really necessary?
    Upponi SS; McIntosh SA; Wishart GC; Balan KK; Purushotham AD
    Eur J Surg Oncol; 2002 Aug; 28(5):479-80. PubMed ID: 12356023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of the extended indications for sentinel node biopsy on the identification of metastasis-free and metastatic sentinel nodes.
    Martinaitis L; Dambrauskas Ž; Boguševičius A
    Medicina (Kaunas); 2015 Nov; 51(5):291-5. PubMed ID: 26674147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of sentinel lymph nodes in breast cancer.
    Cserni G
    Histopathology; 2005 Jun; 46(6):697-702. PubMed ID: 15910602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evaluation of intraoperative touch imprint cytology of sentinel lymph node for breast cancer].
    Huang XY; Wu J; Xu WP; Wang LF; Shi DR; Zhou M; Zhang JX; Han QX; Shen KW; Shen ZZ; Shao ZM
    Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):596-9. PubMed ID: 18210879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sentinel lymph node biopsy for breast cancer: indications, contraindications, and new directions.
    Cody HS
    J Surg Oncol; 2007 May; 95(6):440-2. PubMed ID: 17458860
    [No Abstract]   [Full Text] [Related]  

  • 40. Sentinel lymph node biopsy after neo-adjuvant chemotherapy in patients with breast cancer: Are the current false negative rates acceptable?
    Patten DK; Zacharioudakis KE; Chauhan H; Cleator SJ; Hadjiminas DJ
    Breast; 2015 Aug; 24(4):318-20. PubMed ID: 25800381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.